Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

17 beta-Estradiol-mediated growth inhibition of MDA-MB-468 cells stably transfected with the estrogen receptor: cell cycle effects.

Wang W, Smith R 3rd, Burghardt R, Safe SH.

Mol Cell Endocrinol. 1997 Sep 30;133(1):49-62.

PMID:
9359472
2.
3.

Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNA.

Lin VC, Ng EH, Aw SE, Tan MG, Ng EH, Chan VS, Ho GH.

Clin Cancer Res. 1999 Feb;5(2):395-403.

4.

DDT mimicks estradiol stimulation of breast cancer cells to enter the cell cycle.

Dees C, Askari M, Foster JS, Ahamed S, Wimalasena J.

Mol Carcinog. 1997 Feb;18(2):107-14.

PMID:
9049186
5.

Growth factors and chemotherapeutic modulation of breast cancer cells.

Ciftci K, Su J, Trovitch PB.

J Pharm Pharmacol. 2003 Aug;55(8):1135-41.

PMID:
12956904
6.

Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.

Reddel RR, Murphy LC, Hall RE, Sutherland RL.

Cancer Res. 1985 Apr;45(4):1525-31.

7.

Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.

Jiang C, Guo J, Wang Z, Xiao B, Lee HJ, Lee EO, Kim SH, Lu J.

Breast Cancer Res. 2007;9(6):R77.

8.
9.
11.
13.

Characterization of a nontumorigenic human breast epithelial cell line stably transfected with the human estrogen receptor (ER) cDNA.

Lundholt BK, Madsen MW, Lykkesfeldt AE, Petersen OW, Briand P.

Mol Cell Endocrinol. 1996 May 17;119(1):47-59.

PMID:
8793853
14.

1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.

Vanderlaag K, Su Y, Frankel AE, Grage H, Smith R 3rd, Khan S, Safe S.

Breast Cancer Res Treat. 2008 May;109(2):273-83. Epub 2007 Jul 12.

PMID:
17624585
15.

Chemotherapy cytotoxicity of human MCF-7 and MDA-MB 231 breast cancer cells is altered by osteoblast-derived growth factors.

Koutsilieris M, Reyes-Moreno C, Choki I, Sourla A, Doillon C, Pavlidis N.

Mol Med. 1999 Feb;5(2):86-97.

18.

Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status.

Nesaretnam K, Stephen R, Dils R, Darbre P.

Lipids. 1998 May;33(5):461-9.

PMID:
9625593
19.

Identification of genes involved in growth inhibition of breast cancer cells transduced with estrogen receptor.

Licznar A, Caporali S, Lucas A, Weisz A, Vignon F, Lazennec G.

FEBS Lett. 2003 Oct 23;553(3):445-50.

20.

An anchorage-dependent signal distinct from p42/44 MAP kinase activation is required for cell cycle progression.

Le Gall M, Grall D, Chambard JC, Pouysségur J, Van Obberghen-Schilling E.

Oncogene. 1998 Sep 10;17(10):1271-7.

Supplemental Content

Support Center